Biogazelle and Bio-Rad have established a strong and long-lasting partnership, building on our shared focus of delivering state-of-the-art tools and high quality services and products.
Biogazelle has developed in collaboration with Bio-Rad the commercially available PrimePCR assays. These include a collection of a total of more than 312,000 individual real-time PCR assays for all protein coding genes for human, mouse, rat and another 10 commonly studied species. These assays were designed and in silico validated using Biogazelle’s primerXL assay design engine. All human, mouse and rat assays were wet lab validated beyond international lab standards. In the near future, the PrimePCR portfolio will be expanded with the addition of qPCR assays for human long non-coding RNAs.
Biogazelle also acts as a reference center for Bio-Rad’s digital droplet PCR (ddPCR) system in Europe.
Finally, Bio-Rad provides their CFX qPCR customers with Biogazelle’s qbase+ software for accurate gene expression analysis.
Bio-Rad Laboratories is a referent in the Life Sciences market, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in California, has more than 6500 employees, and serves more than 85,000 research and industry customers worldwide.